Ly96 Mouse (-)-demecolcine increases expression ISO LY96 (Homo sapiens) 6480464 Demecolcine results in increased expression of LY96 mRNA CTD PMID:23649840 Ly96 Mouse 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of LY96 mRNA CTD PMID:22206623 Ly96 Mouse 1-naphthyl isothiocyanate increases expression ISO Ly96 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of LY96 mRNA CTD PMID:25380136 Ly96 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LY96 mRNA CTD PMID:21570461 Ly96 Mouse 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO LY96 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 Ly96 Mouse 2-palmitoylglycerol increases expression ISO LY96 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of LY96 mRNA CTD PMID:37199045 Ly96 Mouse 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 Ly96 Mouse 4,4'-diaminodiphenylmethane increases expression ISO Ly96 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LY96 mRNA CTD PMID:25380136 and PMID:30723492 Ly96 Mouse 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LY96 mRNA CTD PMID:18648102 Ly96 Mouse 4,4'-sulfonyldiphenol multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 Ly96 Mouse 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of LY96 mRNA CTD PMID:19191707 Ly96 Mouse 6-propyl-2-thiouracil increases expression ISO Ly96 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of LY96 mRNA CTD PMID:30047161 Ly96 Mouse acetamide increases expression ISO Ly96 (Rattus norvegicus) 6480464 acetamide results in increased expression of LY96 mRNA CTD PMID:31881176 Ly96 Mouse adenosine increases expression ISO LY96 (Homo sapiens) 6480464 Adenosine results in increased expression of LY96 mRNA CTD PMID:21538184 Ly96 Mouse aflatoxin B1 affects expression ISO LY96 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of LY96 protein CTD PMID:20106945 Ly96 Mouse aflatoxin B1 increases expression ISO LY96 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of LY96 mRNA CTD PMID:21632981 and PMID:21641981 Ly96 Mouse Aflatoxin B2 alpha decreases methylation ISO LY96 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of LY96 intron CTD PMID:30157460 Ly96 Mouse aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of LY96 mRNA CTD PMID:33448797 Ly96 Mouse aldehydo-D-glucose multiple interactions EXP 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 Ly96 Mouse amitrole increases expression ISO Ly96 (Rattus norvegicus) 6480464 Amitrole results in increased expression of LY96 mRNA CTD PMID:30047161 Ly96 Mouse amphetamine increases expression ISO Ly96 (Rattus norvegicus) 6480464 Amphetamine results in increased expression of LY96 mRNA CTD PMID:30779732 Ly96 Mouse antirheumatic drug decreases expression ISO LY96 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of LY96 mRNA CTD PMID:24449571 Ly96 Mouse arsane multiple interactions ISO LY96 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA CTD PMID:32525701 Ly96 Mouse arsenic atom multiple interactions ISO LY96 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA CTD PMID:32525701 Ly96 Mouse arsenite(3-) multiple interactions ISO LY96 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to LY96 mRNA] CTD PMID:32406909 Ly96 Mouse arsenous acid increases expression ISO LY96 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LY96 mRNA CTD PMID:26705709 and PMID:27829220 Ly96 Mouse arsenous acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA CTD PMID:25913414 Ly96 Mouse atazanavir sulfate multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA CTD PMID:33819548 Ly96 Mouse azathioprine increases expression ISO LY96 (Homo sapiens) 6480464 Azathioprine results in increased expression of LY96 mRNA CTD PMID:22623647 Ly96 Mouse benzene increases expression ISO LY96 (Homo sapiens) 6480464 Benzene results in increased expression of LY96 mRNA CTD PMID:33064461 Ly96 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of LY96 mRNA CTD PMID:22228805 Ly96 Mouse benzo[a]pyrene affects methylation ISO LY96 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LY96 intron CTD PMID:30157460 Ly96 Mouse benzo[a]pyrene increases methylation ISO LY96 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LY96 exon CTD PMID:27901495 Ly96 Mouse benzo[a]pyrene increases expression ISO LY96 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of LY96 mRNA CTD PMID:20106945 more ... Ly96 Mouse benzo[e]pyrene decreases methylation ISO LY96 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of LY96 intron CTD PMID:30157460 Ly96 Mouse bis(2-chloroethyl) sulfide increases expression ISO LY96 (Homo sapiens) 6480464 Mustard Gas results in increased expression of LY96 mRNA CTD PMID:25102026 Ly96 Mouse bisphenol A increases expression ISO Ly96 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of LY96 mRNA CTD PMID:25181051 Ly96 Mouse bisphenol A multiple interactions ISO LY96 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LY96 gene CTD PMID:31601247 Ly96 Mouse bisphenol A affects binding ISO LY96 (Homo sapiens) 6480464 bisphenol A binds to [TLR4 protein binds to LY96 protein] CTD PMID:33706241 Ly96 Mouse bisphenol A increases expression ISO LY96 (Homo sapiens) 6480464 bisphenol A results in increased expression of LY96 mRNA CTD PMID:25047013 and PMID:27685785 Ly96 Mouse bortezomib multiple interactions ISO LY96 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA CTD PMID:25913414 Ly96 Mouse butanal increases expression ISO LY96 (Homo sapiens) 6480464 butyraldehyde results in increased expression of LY96 mRNA CTD PMID:26079696 Ly96 Mouse cadmium atom increases expression ISO LY96 (Homo sapiens) 6480464 Cadmium results in increased expression of LY96 mRNA CTD PMID:21120746 Ly96 Mouse cadmium dichloride increases methylation ISO Ly96 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased methylation of LY96 promoter CTD PMID:22457795 Ly96 Mouse cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of LY96 mRNA CTD PMID:26352046 Ly96 Mouse calcitriol increases expression ISO LY96 (Homo sapiens) 6480464 Calcitriol results in increased expression of LY96 mRNA CTD PMID:21592394 Ly96 Mouse calcitriol multiple interactions ISO LY96 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LY96 mRNA CTD PMID:21592394 Ly96 Mouse cannabidiol decreases expression ISO LY96 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of LY96 mRNA CTD PMID:27932991 Ly96 Mouse carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of LY96 mRNA CTD PMID:25554681 Ly96 Mouse chenodeoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 Ly96 Mouse chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of LY96 mRNA CTD PMID:37019170 Ly96 Mouse chromium(6+) multiple interactions ISO LY96 (Homo sapiens) 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of LY96 mRNA CTD PMID:38479592 Ly96 Mouse cobalt dichloride multiple interactions ISO LY96 (Homo sapiens) 6480464 cobaltous chloride results in increased activity of [TLR4 protein binds to LY96 protein] CTD PMID:25803856 Ly96 Mouse cobalt dichloride increases expression ISO Ly96 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of LY96 mRNA CTD PMID:24386269 Ly96 Mouse copper atom multiple interactions ISO LY96 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of LY96 mRNA CTD PMID:20971185 Ly96 Mouse copper(0) multiple interactions ISO LY96 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of LY96 mRNA CTD PMID:20971185 Ly96 Mouse copper(II) sulfate increases expression ISO LY96 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of LY96 mRNA CTD PMID:19549813 Ly96 Mouse cyclosporin A increases expression ISO LY96 (Homo sapiens) 6480464 Cyclosporine results in increased expression of LY96 mRNA CTD PMID:20106945 more ... Ly96 Mouse cyclosporin A multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA CTD PMID:33819548 Ly96 Mouse D-glucose multiple interactions EXP 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 Ly96 Mouse D-glucose increases expression EXP 6480464 Glucose results in increased expression of LY96 mRNA CTD PMID:33448797 Ly96 Mouse deoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 Ly96 Mouse dexamethasone multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 Ly96 Mouse diarsenic trioxide multiple interactions ISO LY96 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA CTD PMID:25913414 Ly96 Mouse diarsenic trioxide increases expression ISO LY96 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LY96 mRNA CTD PMID:26705709 and PMID:27829220 Ly96 Mouse Dibutyl phosphate affects expression ISO LY96 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of LY96 mRNA CTD PMID:37042841 Ly96 Mouse dioxygen multiple interactions EXP 6480464 LY96 results in increased susceptibility to [Oxygen deficiency co-treated with Blood Glucose deficiency] CTD PMID:28063877 Ly96 Mouse diuron decreases expression ISO LY96 (Homo sapiens) 6480464 Diuron results in decreased expression of LY96 mRNA CTD PMID:35967413 Ly96 Mouse dorsomorphin multiple interactions ISO LY96 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA CTD PMID:27188386 Ly96 Mouse doxorubicin multiple interactions ISO Ly96 (Rattus norvegicus) 6480464 [Doxorubicin co-treated with Fungal Polysaccharides] results in decreased expression of LY96 mRNA CTD PMID:27181935 Ly96 Mouse doxorubicin decreases expression ISO LY96 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LY96 mRNA CTD PMID:29803840 Ly96 Mouse epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of LY96 mRNA CTD PMID:35436446 Ly96 Mouse ethanol multiple interactions ISO Ly96 (Rattus norvegicus) 6480464 platycodin D inhibits the reaction [Ethanol results in increased expression of LY96 mRNA] CTD PMID:28852734 Ly96 Mouse ethanol increases expression ISO Ly96 (Rattus norvegicus) 6480464 Ethanol results in increased expression of LY96 mRNA CTD PMID:28852734 Ly96 Mouse ethyl methanesulfonate increases expression ISO LY96 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of LY96 mRNA CTD PMID:23649840 Ly96 Mouse ferroheme b affects binding EXP 6480464 Heme binds to LY96 protein CTD PMID:36115635 Ly96 Mouse ferroheme b multiple interactions EXP 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Heme promotes the reaction [TLR4 protein binds to LY96 protein]] more ... CTD PMID:36115635 Ly96 Mouse fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of LY96 mRNA CTD PMID:28329830 Ly96 Mouse folic acid decreases expression ISO LY96 (Homo sapiens) 6480464 Folic Acid results in decreased expression of LY96 mRNA CTD PMID:28752528 Ly96 Mouse folic acid increases expression ISO LY96 (Homo sapiens) 6480464 Folic Acid deficiency results in increased expression of LY96 mRNA CTD PMID:28752528 Ly96 Mouse formaldehyde increases expression ISO LY96 (Homo sapiens) 6480464 Formaldehyde results in increased expression of LY96 mRNA CTD PMID:23649840 and PMID:27664576 Ly96 Mouse fucoxanthin multiple interactions EXP 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 Ly96 Mouse fulvestrant multiple interactions ISO LY96 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LY96 gene CTD PMID:31601247 Ly96 Mouse gentamycin increases expression ISO Ly96 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of LY96 mRNA CTD PMID:22061828 Ly96 Mouse glucose multiple interactions EXP 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 Ly96 Mouse glucose increases expression EXP 6480464 Glucose results in increased expression of LY96 mRNA CTD PMID:33448797 Ly96 Mouse glycochenodeoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 Ly96 Mouse glycocholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 Ly96 Mouse glycodeoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 Ly96 Mouse glycyrrhetinate multiple interactions EXP 6480464 Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]] CTD PMID:28213090 Ly96 Mouse glycyrrhetinic acid multiple interactions EXP 6480464 Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]] CTD PMID:28213090 Ly96 Mouse heme b affects binding EXP 6480464 Heme binds to LY96 protein CTD PMID:36115635 Ly96 Mouse heme b multiple interactions EXP 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Heme promotes the reaction [TLR4 protein binds to LY96 protein]] more ... CTD PMID:36115635 Ly96 Mouse hydrogen peroxide increases expression ISO LY96 (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of LY96 mRNA CTD PMID:34581912 Ly96 Mouse hydroquinone increases expression ISO LY96 (Homo sapiens) 6480464 hydroquinone results in increased expression of LY96 mRNA CTD PMID:31256213 Ly96 Mouse indole-3-methanol affects expression ISO Ly96 (Rattus norvegicus) 6480464 indole-3-carbinol affects the expression of LY96 mRNA CTD PMID:21396975 Ly96 Mouse indometacin multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 Ly96 Mouse lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of LY96 mRNA CTD PMID:20542052 Ly96 Mouse lipopolysaccharide decreases response to substance ISO LY96 (Homo sapiens) 6480464 LY96 exon mutant form results in decreased susceptibility to Lipopolysaccharides and LY96 protein mutant form results in decreased susceptibility to Lipopolysaccharides CTD PMID:16367934 Ly96 Mouse lipopolysaccharide increases expression ISO LY96 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of LY96 mRNA CTD PMID:26037075 Ly96 Mouse lipopolysaccharide affects binding ISO LY96 (Homo sapiens) 6480464 Lipopolysaccharides binds to [TLR4 protein binds to LY96 protein] and Lipopolysaccharides binds to LY96 protein CTD PMID:26037075 and PMID:28063877 Ly96 Mouse lipopolysaccharide increases response to substance EXP 6480464 LY96 protein results in increased susceptibility to Lipopolysaccharides CTD PMID:16367934 Ly96 Mouse lipopolysaccharide multiple interactions ISO LY96 (Homo sapiens) 6480464 1-(3 more ... CTD PMID:20700758 more ... Ly96 Mouse melatonin multiple interactions ISO Ly96 (Rattus norvegicus) 6480464 Melatonin inhibits the reaction [tetrachlorobenzoquinone results in increased expression of LY96 protein] more ... CTD PMID:27413111 and PMID:28238930 Ly96 Mouse mercury dichloride increases expression ISO Ly96 (Rattus norvegicus) 6480464 Mercuric Chloride results in increased expression of LY96 mRNA CTD PMID:16507785 Ly96 Mouse methamphetamine increases expression ISO LY96 (Homo sapiens) 6480464 Methamphetamine results in increased expression of LY96 mRNA CTD PMID:25290377 Ly96 Mouse methapyrilene decreases methylation ISO LY96 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of LY96 intron CTD PMID:30157460 Ly96 Mouse methimazole increases expression ISO Ly96 (Rattus norvegicus) 6480464 Methimazole results in increased expression of LY96 mRNA CTD PMID:30047161 Ly96 Mouse methotrexate decreases expression ISO LY96 (Homo sapiens) 6480464 Methotrexate results in decreased expression of LY96 mRNA CTD PMID:17400583 Ly96 Mouse methyl methanesulfonate increases expression ISO LY96 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of LY96 mRNA CTD PMID:23649840 Ly96 Mouse Morroniside affects binding EXP 6480464 morroniside binds to [TLR4 protein binds to LY96 protein] CTD PMID:34029560 Ly96 Mouse N-methylformamide affects expression EXP 6480464 methylformamide affects the expression of LY96 mRNA and methylformamide analog affects the expression of LY96 mRNA CTD PMID:17040096 Ly96 Mouse N-nitrosodiethylamine increases expression ISO LY96 (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of LY96 mRNA CTD PMID:21527772 Ly96 Mouse N-nitrosodimethylamine increases expression ISO Ly96 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of LY96 mRNA CTD PMID:25380136 Ly96 Mouse nefazodone multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA CTD PMID:33819548 Ly96 Mouse nickel dichloride multiple interactions ISO LY96 (Homo sapiens) 6480464 nickel chloride results in increased activity of [TLR4 protein binds to LY96 protein] CTD PMID:25803856 Ly96 Mouse O-methyleugenol increases expression ISO LY96 (Homo sapiens) 6480464 methyleugenol results in increased expression of LY96 mRNA CTD PMID:32234424 Ly96 Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of LY96 mRNA CTD PMID:17562736 Ly96 Mouse paracetamol multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA CTD PMID:33819548 Ly96 Mouse paracetamol multiple interactions EXP 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of LY96 mRNA] CTD PMID:29246445 Ly96 Mouse paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of LY96 mRNA CTD PMID:29246445 Ly96 Mouse paracetamol decreases expression ISO LY96 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LY96 mRNA CTD PMID:21420995 and PMID:26690555 Ly96 Mouse paraquat increases expression ISO LY96 (Homo sapiens) 6480464 Paraquat results in increased expression of LY96 mRNA CTD PMID:34097952 and PMID:34681664 Ly96 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LY96 mRNA CTD PMID:36331819 Ly96 Mouse phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LY96 mRNA] CTD PMID:19482888 Ly96 Mouse phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of LY96 mRNA CTD PMID:19270015 and PMID:19482888 Ly96 Mouse phenylmercury acetate multiple interactions ISO LY96 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA CTD PMID:27188386 Ly96 Mouse platycodin D multiple interactions ISO Ly96 (Rattus norvegicus) 6480464 platycodin D inhibits the reaction [Ethanol results in increased expression of LY96 mRNA] CTD PMID:28852734 Ly96 Mouse prednisolone decreases expression ISO LY96 (Homo sapiens) 6480464 Prednisolone results in decreased expression of LY96 mRNA CTD PMID:17379860 Ly96 Mouse pregnenolone 16alpha-carbonitrile increases expression ISO Ly96 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of LY96 mRNA CTD PMID:30047161 Ly96 Mouse procyanidin B1 affects binding ISO LY96 (Homo sapiens) 6480464 procyanidin B1 binds to [TLR4 protein binds to LY96 protein] CTD PMID:26037075 Ly96 Mouse procyanidin B1 multiple interactions ISO LY96 (Homo sapiens) 6480464 procyanidin B1 inhibits the reaction [Lipopolysaccharides results in increased expression of LY96 mRNA] CTD PMID:26037075 Ly96 Mouse propanal increases expression ISO LY96 (Homo sapiens) 6480464 propionaldehyde results in increased expression of LY96 mRNA CTD PMID:26079696 Ly96 Mouse quercetin increases expression ISO LY96 (Homo sapiens) 6480464 Quercetin results in increased expression of LY96 mRNA CTD PMID:21632981 Ly96 Mouse SB 431542 multiple interactions ISO LY96 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA CTD PMID:27188386 Ly96 Mouse silicon dioxide increases expression ISO LY96 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of LY96 mRNA and Silicon Dioxide results in increased expression of LY96 mRNA CTD PMID:25351596 more ... Ly96 Mouse silver atom increases expression ISO LY96 (Homo sapiens) 6480464 Silver results in increased expression of LY96 mRNA CTD PMID:22342292 Ly96 Mouse silver(0) increases expression ISO LY96 (Homo sapiens) 6480464 Silver results in increased expression of LY96 mRNA CTD PMID:22342292 Ly96 Mouse sodium arsenate multiple interactions ISO LY96 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA CTD PMID:32525701 Ly96 Mouse sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of LY96 mRNA CTD PMID:31233874 Ly96 Mouse sodium arsenite decreases methylation EXP 6480464 sodium arsenite results in decreased methylation of LY96 gene CTD PMID:32068019 Ly96 Mouse sodium arsenite increases expression ISO LY96 (Homo sapiens) 6480464 sodium arsenite results in increased expression of LY96 mRNA CTD PMID:23876855 more ... Ly96 Mouse sodium dichromate decreases expression ISO LY96 (Homo sapiens) 6480464 sodium bichromate results in decreased expression of LY96 mRNA CTD PMID:17685462 Ly96 Mouse succimer multiple interactions ISO LY96 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LY96 mRNA CTD PMID:26378955 Ly96 Mouse tartrazine multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA CTD PMID:33819548 Ly96 Mouse temozolomide decreases expression ISO LY96 (Homo sapiens) 6480464 Temozolomide results in decreased expression of LY96 mRNA CTD PMID:31758290 Ly96 Mouse tert-butyl hydroperoxide multiple interactions ISO LY96 (Homo sapiens) 6480464 1-(3 more ... CTD PMID:28063877 and PMID:29111459 Ly96 Mouse testosterone multiple interactions ISO LY96 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LY96 mRNA CTD PMID:21592394 Ly96 Mouse testosterone increases expression ISO LY96 (Homo sapiens) 6480464 Testosterone results in increased expression of LY96 mRNA CTD PMID:21592394 Ly96 Mouse tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LY96 mRNA CTD PMID:27339419 and PMID:31919559 Ly96 Mouse tetrachloromethane multiple interactions EXP 6480464 [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of LY96 mRNA CTD PMID:29987408 Ly96 Mouse tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LY96 mRNA CTD PMID:29987408 Ly96 Mouse thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of LY96 mRNA CTD PMID:26006729 and PMID:26217789 Ly96 Mouse titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of LY96 mRNA CTD PMID:23557971 Ly96 Mouse triclosan decreases expression ISO LY96 (Homo sapiens) 6480464 Triclosan results in decreased expression of LY96 mRNA CTD PMID:34681664 Ly96 Mouse triphenyl phosphate affects expression ISO LY96 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of LY96 mRNA CTD PMID:37042841 Ly96 Mouse tris(2-butoxyethyl) phosphate affects expression ISO LY96 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of LY96 mRNA CTD PMID:29024780 Ly96 Mouse troglitazone increases expression ISO LY96 (Homo sapiens) 6480464 troglitazone results in increased expression of LY96 mRNA CTD PMID:25572481 Ly96 Mouse tungsten increases expression EXP 6480464 Tungsten results in increased expression of LY96 mRNA CTD PMID:30912803 Ly96 Mouse valproic acid decreases expression ISO LY96 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LY96 mRNA CTD PMID:29154799 Ly96 Mouse vincristine increases expression ISO LY96 (Homo sapiens) 6480464 Vincristine results in increased expression of LY96 mRNA CTD PMID:23649840 Ly96 Mouse zinc atom affects expression ISO LY96 (Homo sapiens) 6480464 Zinc affects the expression of LY96 mRNA CTD PMID:16979875 Ly96 Mouse zinc(0) affects expression ISO LY96 (Homo sapiens) 6480464 Zinc affects the expression of LY96 mRNA CTD PMID:16979875